Search for other papers by Jean-Pierre St Mart in
Google Scholar
PubMed
Search for other papers by En Lin Goh in
Google Scholar
PubMed
Search for other papers by Zameer Shah in
Google Scholar
PubMed
heterotopic ossification associated with ROBODOC and CASPAR. 28 , 41 Data regarding intra-operative blood loss are inconclusive. Siebel et al noted that there was significantly greater blood loss with CASPAR. 28 Subsequently, Illgen et al found that
Search for other papers by E. Carlos Rodríguez-Merchán in
Google Scholar
PubMed
criteria for discharge on the day of surgery (DOS): 4 < 500 mL intraoperative blood loss; back in patient ward before 3 pm; received instruction from physiatrist and is safely mobilized; no clinical symptoms of anaemia (paleness, dizziness during
Search for other papers by Kamil Cagri Kose in
Google Scholar
PubMed
Search for other papers by Omer Bozduman in
Google Scholar
PubMed
Search for other papers by Ali Erkan Yenigul in
Google Scholar
PubMed
Search for other papers by Servet Igrek in
Google Scholar
PubMed
, to previous infection, to blood loss and to prolonged operative time. Underlying co-morbidities like insulin-dependent diabetes mellitus and chronic steroid use and the use of TNF alpha-blockers are also important risk factors for infection
Search for other papers by Ioannis V. Papachristos in
Google Scholar
PubMed
NIHR Leeds Biomedical Research Unit, Chapel Allerton Hospital, Leeds, UK
Search for other papers by Peter V. Giannoudis in
Google Scholar
PubMed
treatment is safe, taking into account a greater peri-operative blood loss. 17 Noteworthy, for neuraxial anaesthesia, in the case of clopidogrel or newer antiplatelet drugs prasugrel and ticagrelor, five to seven days of drug cessation are needed prior
Search for other papers by Rafik Yassa in
Google Scholar
PubMed
Search for other papers by Mahdi Yacine Khalfaoui in
Google Scholar
PubMed
Search for other papers by Ihab Hujazi in
Google Scholar
PubMed
Search for other papers by Hannah Sevenoaks in
Google Scholar
PubMed
Search for other papers by Paul Dunkow in
Google Scholar
PubMed
that there was no difference in bleeding complications, blood loss or transfusion requirements, when compared with those not on antiplatelets. 65 Furthermore, hospital length of stay and overall mortality were also not affected. In a separate study
Search for other papers by Karl Stoffel in
Google Scholar
PubMed
Search for other papers by Christoph Sommer in
Google Scholar
PubMed
Search for other papers by Mark Lee in
Google Scholar
PubMed
Search for other papers by Tracy Y Zhu in
Google Scholar
PubMed
Search for other papers by Karsten Schwieger in
Google Scholar
PubMed
Search for other papers by Christopher Finkemeier in
Google Scholar
PubMed
) No difference in age, gender, no. of extra location of fractures; Significantly more traffic accidents (83.3% vs 16.7%), type C fracture (100% vs 54.2%), open fracture (91.7% vs 52%) in DP group. No difference in surgery duration and blood loss
Search for other papers by Julie J. Willeumier in
Google Scholar
PubMed
Search for other papers by Yvette M. van der Linden in
Google Scholar
PubMed
Search for other papers by Michiel A.J. van de Sande in
Google Scholar
PubMed
Search for other papers by P.D. Sander Dijkstra in
Google Scholar
PubMed
kidney and thyroid cancer, pre-operative embolisation of the metastasis is advised to prevent excessive peri-operative blood loss. 24 Surgery should be performed within 72 hours following embolisation. For all pathological fractures of the long
Search for other papers by Enrique Gómez-Barrena in
Google Scholar
PubMed
Search for other papers by Christian Ehrnthaller in
Google Scholar
PubMed
with RIA harvesting (up to 44%) ( 60 ) has been substantially decreased (down to 14%) ( 61 ) in other reports. The risk of cortical perforation and the frequently reported relevant intraoperative blood loss are complications that should be anticipated
Search for other papers by Jasmine N. Levesque in
Google Scholar
PubMed
Search for other papers by Ajay Shah in
Google Scholar
PubMed
Search for other papers by Seper Ekhtiari in
Google Scholar
PubMed
Search for other papers by James R. Yan in
Google Scholar
PubMed
Search for other papers by Patrick Thornley in
Google Scholar
PubMed
Search for other papers by Dale S. Williams in
Google Scholar
PubMed
expected low quality of evidence overall, a meta-analysis was not planned. A qualitative assessment of peri-operative outcomes (estimated blood loss (EBL), operative time, and fluoroscopy use) was performed using high-quality (i.e. Level I and Level II
Universidad Autònoma de Barcelona (UAB), Bellaterra, Barcelona, Spain
Search for other papers by Pablo Castillón in
Google Scholar
PubMed
Department of Trauma and Orthopaedic Surgery, Hospital Nostra Senyora de Meritxell, Andorra
Search for other papers by Josep Maria Muñoz Vives in
Google Scholar
PubMed
Universidad de Valladolid, Valladolid, Spain
Search for other papers by Héctor José Aguado in
Google Scholar
PubMed
Search for other papers by Arantxa Capel Agundez in
Google Scholar
PubMed
Search for other papers by Alina Ortega-Briones in
Google Scholar
PubMed
Universidad Autònoma de Barcelona (UAB), Bellaterra, Barcelona, Spain
Search for other papers by Jorge Hassan Núñez in
Google Scholar
PubMed
Search for other papers by the PISCO Investigators † in
Google Scholar
PubMed
treatment for PPFFs fixation ( 28 , 29 , 30 ). Kanakaris et al. and Wood et al. discussed that despite the potential advantage of smaller less invasive procedures with less blood loss and improved fracture biology, this should not be at the expense of
